ACT

OCT. 25/2016

news roundup

EMA Opens Access to Clinical Data to All

The EMA website includes the clinical reports contained in all initial MAAs submitted on or after the policy took effect on January 1, 2015.


advertisment

Click here and press play in our video player to watch a short video about Covance's Xcellerate Insights collaborative workspace, making sharing and information access among project teams easier, more secure, and more efficient.


CDISC Standards Key to Meeting FDA Goals

Data standards, such as CDISC, are "at the heart of linking different data streams" to assess safety issues from thousands of safety reports and connect the dots from pre-clinical and clinical studies to real world health issues.


advertisment

Your patient safety is at risk without real-time surveillance. This ERT webinar (November 3rd at 11am EDT) will give you tools and systems to automate oversight and surveillance of PDVs, reduce issue resolution cycle times, and proactively identify and mitigate risks.
Click here to register


Medidata Launches AppConnect Partner Program

The AppConnect Partner Program combines the company's cloud and mHealth technology with access to digital health firms.


advertisment

Read this interview with IBM company (eClinical Division), discusses risk-based monitoring (RBM) and how the company is innovating a 25-year-old manual process to enable better monitoring decisions.
Learn more

advertisment

In this edition

EMA Opens Access to Clinical Data to All
Assessing Global Clinical Supply Issues
Europe Lags Behind US in Biopharm Support
RBM—Risk-Based Trial Management and Monitoring

advertisment

The Next Wave of Centralized Monitoring
Live Webinar: Thursday, November 10 at 11:00 AM EST
Register now


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Articles

Assessing Global Clinical Supply Issues

A recent survey of 250 supply chain executives found that two-thirds anticipated significantly increasing spending on clinical trial logistics over the next two years.

Events

Risk-Based Trial Management and Monitoring
CBI's 2nd Annual Clinical R&D Financial Tracking & Analysis Summit
eCOA/ePRO Summit
Search more events

Test Your Knowledge

What's Your Drug Regulatory Knowledge?
Medical Device pros…how well do you know regulatory for drug development?
LEARN MORE

advertisment

Vendor Overload? Integrating third party lab management to streamline clinical development
Live Webinar: Thursday, October 27 at 11:00 EDT
Register now


Risk-Based Monitoring

Risk-Based Trial Management and Monitoring: Register Now, Starts Next Week!


advertisment

The Evolution of Regulatory Affairs
Live Webinar: Wednesday, December 7 at 11:00am EST
Register now


The Core of RBM is Centralized Monitoring

Recent research indicates that the implementation of risk-based monitoring (RBM) – particularly using centralized monitoring as a core component of clinical trial execution – is impacting clinical trials of all sizes, indications and phases.


advertisment

Drive better outcomes with improved trial design
Live Webinar: Tuesday, December 6 at 11am EST
Register now


FDA RBM Guidance Still Misinterpreted

Clinical operations personnel are currently focusing on the last step of the risk management process, rather than looking at the holistic approach towards risk mitigation through proper planning.


RBM's Impact on the Study Sites

As more RBM studies get underway, sites may experience a difference when it comes to sponsor or CRO monitoring methods, but not in how they recruit and care for study participants.


Blog Posts

advertisment

Continuous Glucose Monitoring (CGM) in Clinical Trials: An Evolving Regulatory Landscape
Live Webinar: Tuesday, October 25 at 2:00 PM EST
Register now


Reflections from Partnerships in Clinical Trials

Three key takeaways from the conference focus on technology … the question most heard at the conference was: How do we accelerate adoption of technology?


advertisment

Regulatory Changes in India and What It Means for Clinical Research in the Country
On Demand
Learn More


Europe Lags Behind US in Biopharm Support

European Biopharmaceutical Enterprises says the region's creative potential is frustrated by its insufficient capability to translate basic science into a commercial venture, to define attractive business cases, and to find investment capital to execute a viable business plan.


advertisment

Simplifying the complexities of global rare disease drug development
On Demand
Learn More


Get the full picture

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription


Ask the editor

Lisa Henderson
Editor in Chief
[email protected]

Advertise

Mike Tessalone
Publisher
[email protected]